Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: Evaluation of the effect of MTNR1B rs10830963 gene variant on the therapeutic efficacy of nateglinide in treating type 2 diabetes among Chinese Han patients

Fig. 2

Comparisons of differential values (pre-administration levels subtracted from the post-administration levels) of FPG (A) and HOMA-β (B) between different MTNR1B rs10830963 genotypes in T2DM patients before and after treatment of nateglinide. Data are expressed as (mean ± SD). *P < 0.05 compared with CC genotype group respectively

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us